Monitor for further insider buying filings and clinical trial milestones. The chairman's open-market purchases indicate alignment with minority shareholders; any positive trial news could amplify upside.
Price Chart
Executive Summary
Chairman and Director Choo Chee Kong acquired 112,000 ordinary shares in a private purchase on May 13, 2026, and stated his intention to further increase his stake. This insider buying signals confidence in the company's outlook for this small-cap biotech.
Key Facts
- Chairman Choo Chee Kong bought 112,000 shares via a private agreement with an arm's-length shareholder on May 13, 2026.
- The company was not a party to the transaction and received no proceeds.
- Mr. Choo intends to negotiate additional private purchases to increase his holding.
- Current market cap is approximately $10M, making this a meaningful insider signal.
Financial Impact
Purchase of 112,000 shares at an undisclosed price; insider buying suggests confidence but no direct financial impact on the company.
Risk Factors
- Clinical-stage biotech with no approved products; Phase I trial outcomes are uncertain.
- Low market cap and liquidity may amplify volatility.
- Future insider buying depends on successful negotiation, which may not materialize.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001493152-26-023342 |
| Document: 0001493152-26-023342-index-headers.html | 0001493152-26-023342 |
| Document: 0001493152-26-023342-index.html | 0001493152-26-023342 |
| Document: 0001493152-26-023342.txt | 0001493152-26-023342 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | SC 13G/A | $0.9190 $0.9262 | ▲ +0.78% | ▲ +0.07% | $0.8653 (−5.84%) |
Oct 16, 2026 11d ago | SC 13D/A | $0.8799 $0.8520 | ▼ −3.17% | ▼ −3.59% | $0.8653 (−1.66%) |
Oct 13, 2026 14d ago | SC 13D/A | $0.8700 $0.8599 | ▼ −1.16% | ▼ −0.08% | $0.8653 (−0.54%) |
Oct 9, 2026 17d ago | 6-K | $0.8114 $0.8700 | ▼ −7.22% | ▼ −7.23% | $0.8653 (−6.64%) |
Sep 30, 2026 27d ago | 6-K | $0.8430 $0.8999 | ▼ −6.75% | ▼ −6.57% | $0.8653 (−2.65%) |
May 15, 2026 23w ago | 6-K | $1.16 $1.21 | ▲ +4.31% | ▲ +4.37% | $0.8653 (−25.41%) |
May 11, 2026 24w ago | 6-K | $0.8090 $0.7690 | ▼ −4.94% | ▼ −4.81% | $0.8653 (+6.96%) |
Mar 31, 2026 30w ago | 6-K | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.8653 (−13.47%) |
Mar 31, 2026 30w ago | 20-F | $1.00 $1.03 | ▲ +3.00% | ▲ +2.25% | $0.8653 (−13.47%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers